0000899243-19-019303.txt : 20190708 0000899243-19-019303.hdr.sgml : 20190708 20190708160519 ACCESSION NUMBER: 0000899243-19-019303 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190705 FILED AS OF DATE: 20190708 DATE AS OF CHANGE: 20190708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCracken Joseph S CENTRAL INDEX KEY: 0001632454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32157 FILM NUMBER: 19945393 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Savara Inc CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512-614-1848 MAIL ADDRESS: STREET 1: 900 S. CAPITAL OF TEXAS HIGHWAY STREET 2: SUITE 150 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Mast Therapeutics, Inc. DATE OF NAME CHANGE: 20130312 FORMER COMPANY: FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030613 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-05 0 0001160308 Savara Inc SVRA 0001632454 McCracken Joseph S 6836 BEE CAVE ROAD, BUILDING III SUITE 200 AUSTIN TX 78746 1 0 0 0 Common Stock 2019-07-05 4 M 0 21682 0.82 A 81548 D Common Stock 2019-07-05 4 M 0 2930 0.82 A 84478 D Common Stock 2019-07-05 4 M 0 5860 1.46 A 90338 D Common Stock 2019-07-05 4 M 0 9034 1.76 A 99372 D Stock Option (Right to Buy) 0.82 2019-07-05 4 M 0 21682 0.00 D 2023-11-27 Common Stock 21682 0 D Stock Option (Right to Buy) 0.82 2019-07-05 4 M 0 2930 0.00 D 2024-07-24 Common Stock 2930 0 D Stock Option (Right to Buy) 1.46 2019-07-05 4 M 0 5860 0.00 D 2025-12-15 Common Stock 5860 0 D Stock Option (Right to Buy) 1.76 2019-07-05 4 M 0 9034 0.00 D 2026-12-15 Common Stock 9034 1807 D The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 15, 2014. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014. The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016. The shares subject to the option vest and become exercisable in twelve equal quarterly installments beginning on March 15, 2017. /s/ David Lowrance as attorney-in-fact for Joseph S. McCracken 2019-07-08